ILC Dover Announces Multi-compendial Water for Injection (WFI) for Growing Biotherapeutic and Cell & Gene Therapy Markets
NEWARK, Del. July 28, 2022 —ILC Dover LP (“ILC Dover” or the “Company”), specializing in innovative single-use solutions for biotherapeutics and pharmaceutical processing, announced the launch of Water for Injection (WFI) for the biotherapeutics market. Used for the preparation of media, buffers, and other ingredients for biopharmaceuticals and medical devices, this launch continues to expand … Continued